drugset / Trial / NCT00273026

Study In Asthma Control

NCT00273026 ↗

Phase 4 Terminated 680 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.

Timeline

Start
2004-11-08
Primary completion
—
Completion
2006-03-28

Drugs

EvaluationDrugModalityDoseRoute
Subject salmeterol xinafoate/fluticasone propionate Unknown — —

Indications